Background A vaccine against SARS-CoV-2 is of high urgency. Here the safety and
immunogenicity induced by a DNA vaccine (INO-4800) targeting the full length spike antigen of …

Monoclonal antibody therapy has played an important role against SARS-CoV-2. Strategies
to deliver functional, antibody-based therapeutics with improved in vivo durability are …

Background Vaccines against SARS-CoV-2 are still urgently needed as only 5% of the global
population has been vaccinated. Here we report the safety and immunogenicity of a DNA …

Subpopulations of B-lymphocytes traffic to different sites and organs to provide diverse and
tissue-specific functions. Here, we provide evidence that epigenetic differences confer a …

Osteoporosis is a bone disease characterized by structural deterioration and low bone mass,
leading to fractures and significant health complications. In this review, we summarize the …

Background Additional severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccines that are safe and effective as primary vaccines and boosters remain urgently needed …

Background and aims Epstein–Barr virus (EBV)-associated gastric carcinoma (EBVaGC) is
the most common EBV-associated cancer and accounts for ~ 10% of all gastric cancers (GC). …

The global coronavirus disease 2019 (COVID-19) pandemic has claimed more than 5 million
lives. Emerging variants of concern (VOCs) continually challenge viral control. Directing …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines may target epitopes
that reduce durability or increase the potential for escape from vaccine-induced immunity. …

Despite numerous clinically available vaccines and therapeutics, aged patients remain at
increased risk for COVID-19 morbidity. Furthermore, various patient populations, including the …